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Purpose: To investigate the clinical features and molecular basis of inherited cataract-microcornea caused by an αA-
crystallin gene (CRYAA) mutation in a Chinese family.
Methods: A three-generation Chinese family with members having autosomal dominant cataract and microcornea was
recruited. Genomic DNA from peripheral blood or buccal swab samples of five affected and five unaffected members
were obtained. Based on 15 genes known to cause autosomal dominant cataract, single nucleotide polymorphisms (SNPs)
or microsatellite markers were selected and genotyped for two-point linkage analysis. Direct sequencing was performed
to identify the disease-causing mutation. The expression construct coding for recombinant COOH-terminal myc-His-
tagged wild type or R12C αA-crystallin protein (CRYAA) was expressed in COS-7 cells. Detergent solubility and
subcellular distribution of wild type and R12C CRYAA were examined by western blotting and immunofluorescence,
respectively. Heat-shock response was monitored by quantitative polymerase chain reaction (qPCR) of heat-shock proteins
70 and 90α (HSP70 and HSP90α).
Results: The five affected family members showed variable lens opacities and microcornea. Clinical features of cataract
were asymmetric in two eyes of some affected subjects. A heterozygous missense substitution, c.34C>T, in CRYAA, which
is responsible for the R12C amino acid change, segregated with autosomal dominant cataract (ADCC) in this family. This
substitution was absent in 103 unrelated controls. When expressed in COS-7 cells, the R12C mutant CRYAA resembled
the wild type protein in its solubility when extracted with 0.5% Triton X-100 and with its cytoplasmic localization.
However, mutant cells exhibited an altered heat-shock response, evidenced by the delayed expression of HSP70, when
compared to cells expressing wild type CRYAA.
Conclusions: The R12C mutation in CRYAA was responsible for a variable type of inherited cataract associated with
microcornea in this Chinese family. The altered heat-shock response of mutant cells suggested a change of chaperoning
capacity and networking, which could be associated with the pathogenesis of hereditary cataract-microcornea syndrome.
Congenital or infantile cataract is an opacification of the
lens,  usually  diagnosed  at  birth  or  shortly  thereafter.  Its
prevalence is up to 6 in 10,000 live births, causing about 10%
of childhood blindness worldwide [1-5]. This heterogeneous
disease exhibits considerable phenotypic as well as genetic
variation [6,7]. Genetically, autosomal dominant inheritance
(ADCC) is the most common mode of transmission, though
autosomal recessive and X-linked inherited forms have been
reported. So far, over 26 genes with specific mutations have
been identified to be associated with the onset or progression
of hereditary cataract. Among them, 17 are found for isolated
autosomal  dominant  cataract  without  other  ocular  or
multisystem anomalies including genes coding for crystallins,
membrane  transport  proteins,  cytoskeletal  proteins,
transcription factors, and chromatin modifying proteins [8].
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About 18% of inherited congenital cataracts appear with
a  distinct  phenotype  of  congenital  cataract-microcornea
syndrome (CCMC;  OMIM 116150) [9]. Six genes have been
identified to associate with this particular defect including
three  lens-specific  crystallin  genes  (namely  crystallin  αA
(CRYAA)  [10-13],  crystallin  βB1  (CRYBB1)  [14],  and
crystallin γD (CRYGD) [10]) as well as genes encoding gap
junction  protein α8   (GJA8)  [9,10],  basic  leucine  zipper
transcriptional  factor  (MAF),  [15-17]  and  solute  carrier,
SCL16A12 (a carboxylic acid transporter) [18]. Apart from
that,  one  locus  at  11q13  was  reported  to  be  related  to
microcornea and cataract formation, but no specific gene has
yet been identified [19].
Here,  we  report  a  Chinese  family  exhibiting  variable
cataract  phenotypes  and  variable  microcornea/
microphthalmia  in  an  autosomal  dominant  transmission
fashion. The R12C mutant CRYAA protein demonstrated an
altered  heat-shock  response  but  no  change  of  detergent
solubility  or  subcellular  redistribution.  This  phenotypic
variation could represent a crucial role of CRYAA in cataract
formation.
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Subjects  and  clinical  examinations:  A  three-generation
Chinese  family  with  inherited  cataract  (Figure  1A)  was
recruited  to  the  University  Eye  Center of  The  Chinese
University of Hong Kong (Hong Kong, China). The research
protocol followed the tenets of the Declaration of Helsinki and
was  approved  by  the  ethics  committee  of The  Chinese
University of Hong Kong. Ten family members underwent
complete  ophthalmic  examination  including  slit  lamp
biomicroscopy and ophthalmoscopy. All affected individuals
(I1, II3, II5, II9, and III5) were followed up for eight years
until 2008 by the same senior ophthalmologist in our eye
center.  During  their  last  visit,  additional  ophthalmic
examinations  were  performed  including  corneal  diameter
measurement,  keratometry  (Autokerato-refractometer
KR-7100; Topcon Optical, Tokyo, Japan), anterior segment
optical coherence tomography (1310 nm, Visante OCT Model
1000; Carl Zeiss Meditec, Dublin, CA), and ultrasonography
(Ultrasonic  Pachymeter  SP-3000  and  Biometer  AL-100;
Tomey Corporation, Nagoya, Japan). Slit lamp photography
was  also  performed.  Microcornea  was  defined  as  the
horizontal corneal diameter being shorter than 11 mm [20,
21] and microphthalmia as the antero-posterior axial length of
the adult (normally elder than three) eye globe being shorter
than 20 mm [22,23].
Sample collection and DNA extraction: From five affected
and five unaffected family members, whole blood samples
from  adult  participants  and  buccal  swab  samples  from
children were collected. Genomic DNA was extracted using
the  QIAamp  DNA  kit  (Qiagen,  Valencia,  CA).  Unrelated
subjects without cataracts were recruited as controls.
Candidate gene screening: Fifteen known ADCC-associated
genes were screened by linkage analysis. Thirty-nine single
nucleotide polymorphism (SNP) markers based on 15 genes
(Table 1) were selected with ABI SNP browser version 3.5
(Applied  Biosystems,  Foster  City,  CA).  TaqMan  SNP
genotyping  assay  was  performed  by  ABI  PRISM  7000
sequence detection system (Applied Biosystems) followed by
linkage analysis. For chromosomal regions in which SNPs
were not informative, microsatellite marker analyses were
used. Seventeen microsatellite markers flanking the target
genes (Table 1) were chosen using the Marshfield genetic
map. Genescan was performed with ABI PRISM® 3130xl
analyzer (Applied Biosystems). Two-point LOD scores were
calculated  by  the  MLINK  subprogram  from  FASTLINK
version  4.1P  package.  A  gene  frequency  of  0.0001  and
penetrance of 100% were assumed for ADCC.
Gene sequencing: All coding exons and splice regions of
CRYAA, CRYBA1, and MAF were sequenced with specific
primers (Invitrogen, Carlsbad, CA; Table 2) using BigDye
Figure 1. A Chinese autosomal dominant cataract family. A: Pedigree of a three-generation Chinese family with autosomal dominant cataract
is shown. The asterisk indicates the family members whose DNA samples were analyzed. B: The lens image was taken from subject III5
following pupillary dilation. Both lenses showed the lamellar opacity within the fetal nucleus with a clear peripheral cortex. C: Subject II3
displayed similar lamellar opacity in the right lens and a central dense opacity with sharp margins in the left lens. D: Both images were from
subject II5. A single spherical opacity (indicated by black arrows) was evident in the left lens, and only a smaller dot was found in the right
lens.
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1128terminator v3.1 cycle sequencing kit (Applied Biosystems) on
the ABI PRISMTM 3130xl analyzer. Sequences were analyzed
with  reference  to  the  NCBI  GenBank  (NM_000394  for
CRYAA, NM_005208 for CRYBA1, and NM_001031804 and
NM_005360 for MAF).
Expression constructs: A 548 base pair (bp) EcoR1/Xho1
fragment encompassing the human full length 519 bp open
reading frame of wild type CRYAA was ligated to the EcoR1/
Xho1 site of mammalian expression vector, pcDNA6/myc-
His (Invitrogen). The c.34C>T mutation was introduced by
polymerase  chain  reaction  (PCR)-based  site-directed
mutagenesis  (Stratagene,  Lo  Jolla,  CA)  using  a  specific
oligonucleotide: sense 5′-ATC CAG CAC CCC TGG TTC
AAG TGC ACC CTG GGG CCC TTC TAC C-3′ (the bold
underlined alphabet indicated the specific base change). The
constructs were verified by direct sequencing.
TABLE 1. SNPS AND MICROSATELLITE MARKERS FOR CANDIDATE GENE SCREENING.
Gene Gene ID Position SNP Microsatellite
CRYAA 1409 21q22.3 rs870137 D21S1890
D21S266
CRYAB 1410 11q22–22.3 rs2070894
rs1940392
rs14133
rs10502149
CRYBB1 1414 22q11 rs4822752
rs5752351
rs2071859
rs4822749
rs5761618
CRYBB2 1415 22q11.2 rs739315
rs5752084
rs969623
CRYBA1 1411 17q11.1–12 rs8080081 D17S1873
CRY GC 1420 2q33–35 rs2242071 D2S2208
CRY GD 1421 2q33–35 rs2305429
GRY GS 1427 3q25-qter  rs3774803 D3S1262
rs11917060 D3S3570
rs1447670
rs4686428
MIP 4284 12q12 rs7953824 D12S1632
rs2269348 D12S1691
rs3809125
rs10876890
GJA8 2703 1q21–25 rs7541950
rs2132397
GJA3 2700 13q11–13 rs4769953 D13S1316
rs1886176 D13S175
BFSP2 8419 3q21–22  rs1153876 D3S1290
rs666067 D3S3713
rs4854585 D3S3657
rs6762405 D3S1292
rs931099
PITX3 5309 10q24–25 rs3758553
MAF 4094 16q23.2 rs2288066 D16S3040
D16S504
HSF4 3299 16q22 Hcv25749941 D16S3107
Hcv25613880
rs11642409
rs9033
This table showed all candidate genes studied in the screening experiment. The gene symbol, gene ID in NCBI, gene chromosome
position, SNP markers and microsatellite markers for each gene were listed respectively.
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1129Cell culture and transfection: COS-7 cells (ATCC, Manassas,
VA) were maintained in Eagle’s Minimum Essential medium
(Invitrogen)  supplemented  with  10%  fetal  bovine  serum
(FBS; Invitrogen) and 1% antibiotics at 37 °C in a humidified
condition with 5% CO2 balanced with air. COS-7 cells were
verified to contain negligible endogenous CRYAA by reverse
transcription  polymerase  chain  reaction  (RT–PCR)  and
western  blotting.  CRYAA  expression  constructs  were
transfected to cells at a density of 1.5x104 cells/cm2 by FuGene
HD (Roche, Basel, Switzerland) at a ratio of 1 μg of DNA per 3
μl  of  FuGene  HD  in  Opti-MEM®  I  supplemented  with
GlutaMAXTM I (Invitrogen). Cells were collected for protein
and mRNA analyses 24 h after transfection.
Triton X-100 solubility assay: Cells with a density of 2.5×106
cells/ml were lysed in a buffer containing 100 mM Tris-HCl
(pH  7.4),  3  mM  EGTA  (Sigma,  St  Louis,  MO),  5  mM
TABLE 2. SPECIFIC PRIMERS FOR CRYAA, CRYBA1, AND MAF SEQUENCING.
Gene Primer Primer sequence (5′→3′)
CRYAA
 
1F CTCCAGGTCCCCGTGGTA
1R AGGAGAGGCCAGCACCAC
2F CTGTCTCTGCCAACCCCAG
2R CTGTCCCACCTCTCAGTGCC
3F AATGATCCTGCGATTTTGGAG
3R GGAAGCAAAGGAAGACAGACACC
CRYBA1 1F CGCAGGGCTATAAAGAGGAG
1R GACAAGAGAAGGCTGTCTTCC
2F CCTTTCAAGGTATTCCCTCACC
2R CACTGGAGCTTGTGTGGACC
3F ATGTTCTAGCTCTCTTGCGC
3R GTAGTGATTTCTTTCGAGGCC
4F TGAACACCATGAACAAACACTAC
4R ACGGAAGTGGAAATTTCAGAG
5F CATGTGCTTCCTTGTATAATCC
5R ACTATTGATGCAACCTCAGG
6F CATCTCATACCATTGTGTTGAG
6R ACTTTCTAGAGTGCTTAGCAAGG
MAF 1F CTCCTGCAGCCCATCTGG
1R CTGGTGGCTGTTGCTGATG
2F CATCAGCAACAGCCACCAG
2R GAGAAGCGGTCGTCGAAGT
3F ACTTCGACGACCGCTTCTC
3R TGGCGAGCATGGCTCTAG
4F CCTTTACGCTGCGTTTGATC
4R AACCCCCAGACAAGAGGC
F: forward primer; R: reverse primer.
TABLE 3. EXPRESSION PRIMERS OF HSP90A, HSP70, AND GAPDH.
Gene Primer Primer sequence
HSP90A F ACCCAGACCCAAGACCAACCG
R ATTTGAAATGAGCTCTCTCAG
HSP70 1F AAGTACAAAGCGGAGGACG
1R GATGGGGTTACACACCTGC
2F TGCTGATCCAGGTGTACGAG
2R CGTTGGTGATGGTGATCTTG
GAPDH F GAAGGTGAAGGTCGGAGT
R GAAGATGGTGATGGGATTTC
F: forward primer; R: reverse primer.
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1130MgCl2, 0.5% Triton X-100 (Tx; Sigma), protease inhibitor
cocktail (Roche), and 1 mM phenylmethylsulfonyl fluoride
for  2  min  on  ice.  After  centrifugation,  the  supernatant-
containing Tx-soluble protein was collected and denatured in
a sodium dodecyl sulfate (SDS) sample buffer containing
50 mM DTT. The pellet containing the Tx-insoluble protein
was  washed  twice  with  ice-cold  PBS,  sonicated,  and
denatured in the SDS sample buffer containing 9 M urea. Tx-
soluble and -insoluble proteins equivalent to 7.5×104 cells
were  resolved  by  15%  SDS–polyacrylamide  gel
electrophoresis (PAGE) and by western blotting with mouse
monoclonal antibodies against CRYAA (Abcam, Cambridge,
UK), glyceraldehydes 3-phosphate dehydrogenase (GAPDH;
Abcam),  and  β-actin  (Sigma)  and  with  rabbit  polyclonal
antibodies against myc (Santa Cruz, Santa Cruz, CA), His
(Abcam), and appropriate horseradish peroxidase-conjugated
Ig  secondary  antibodies  (Jackson  ImmunoResearch,  West
Grove,  GA).  The  signals  were  detected  by  enhanced
chemiluminescence (ECL; Amersham, Piscataway, NJ), and
specific  bands  were  quantified  by  Quantity  One  Image
Analysis  software  (Bio-Rad,  Hercules,  CA).  CRYAA
expression  was  normalized  with  GAPDH  (for  Tx-soluble
protein)  or  β-actin  (for  Tx-insoluble  protein).  Three
independent  experiments  were  performed,  and  paired
Student’s  t-test  was  used  to  determine  the  statistical
significance of the data.
Immunofluorescence:  Cells  were  fixed  with  2%
paraformaldehyde  (Sigma)  in  PBS  (0.1  M,  pH  7.4),
permeabilized, and processed for immunofluorescence [24].
The  sample  was  detected  with  mouse  monoclonal  anti-
CRYAA antibody followed by rhodamine Red-X goat anti-
mouse IgG secondary antibody (Invitrogen). After nuclear
staining by 4'-6-diamidino-2-phenylindole (DAPI; Sigma),
samples  were  examined  with  fluorescence  microscopy
(DMRB; Leica, Wetzlar, Germany) equipped with Spot RT
color system (Diagnostic Instruments, Sterling Heights, MI).
Heat-shock analysis: COS-7 cells expressing wild type or
R12C CRYAA were heat-shocked at 42 °C for 20 min and
then returned to 37 °C for different time intervals (0, 20, 40,
60, 120, 240, and 480 min). Total RNA was extracted with the
RNeasy kit (Qiagen), quantified, and reverse-transcribed with
a  random  primer  (Roche)  and  SuperScriptTM  III  reverse
transcriptase  (Invitrogen).  Real-time  PCR  was  performed
with  SYBR  Green/fluorescein  PCR  mix  (Bio-Rad)  and
specific  primers  of  HSP70,  HSP90α,  and  GAPDH
(Invitrogen; Table 3) using the ABI PRISM 7000 sequence
detection  system.  Three  independent  experiments  were
performed.
Computational analysis: Properties of the wild type and R12C
mutant protein were analyzed by some software provided in
the Expasy proteomics server. The isoelectric point (pI) and
molecular  weight  (MW)  were  calculated  by  Compute  pI/
MW.  The  hydrophobicity  change  was  predicted  by
ProtScale.  The  effect  of  the  mutation  was  assessed  by
PolyPhen.
Figure  2.  A  novel  R12C  mutation  of
CRYAA. Sequencing results showed a
substitution  of  C  to  T  in  CRYAA  (c.
34C>T), which led to a R12C amino
acid change. In the upper panel, the wild
type  (WT)  CRYAA  DNA  segment
(starting from the coding position 28)
and its coding amino acid sequence are
listed on the left, and the sequencing
image is shown on the right. The mutant
DNA  and  polypeptide  sequences  and
the sequencing image were shown in the
lower panel. The mutation is indicated
in italic. The sequence change in image
is indicated by arrows.
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1131RESULTS
Clinical features of family subjects: The pedigree exhibited
an autosomal dominant pattern of transmission of infantile
cataract (Figure 1A). Within the family, different phenotypes
of lens opacity were observed in affected individuals between
the two eyes of a subject. The proband (III5) was diagnosed
with bilateral lamellar cataract at one year of age. The lamellar
opacity was located in the fetal nucleus with a more dense
center, and the peripheral lens was clear. During his last visit
at the age of nine, his horizontal corneal diameters were 9.5
and 10 mm in the left and right eyes, respectively (Table 4).
His father (II3) had different types of opacities between his
eyes, which were first documented at 45 years of age, though
he admitted to having eye problems in his younger age. The
right lens had a lamellar type of opacification in the fetal
nucleus whereas a dense nuclear cataract with a sharp margin
was restricted in the left embryonic nucleus without affecting
the fetal nucleus (Figure 1C). In his recent follow-up at the
age of 53, the cataract showed no progression when compared
to  previous  examinations,  and  the  horizontal  corneal
diameters were 9.5 mm in both eyes (Table 4). Both II3 and
III5 exhibited nystagmus, which might be related to the visual
impairment during the early childhood [10]. The sister (II5)
of II3 was first diagnosed with bilateral dot-like cataract in the
cortical region at the age of 44 (Figure 1D). After eight years,
the dotted opacity showed no progression, and the horizontal
corneal  diameter  was  approximately  in  the  normal  range
(10.5 mm; Table 4). Another sister (II9) was identified to have
variable cataract in both eyes at the age of 38. Dot-like opacity
was present in the cortical region of one eye, and the lamellar
type opacity was found in the other. The cataract had no
obvious  progression  during  the  follow-up  period.  The
horizontal corneal diameter was 10 mm when measured at age
46 years (Table 4). As a whole, no progression of lens opacity
was noted in this family during their follow-up visits in the
past eight years, and all eye examinations were performed by
the same senior ophthalmologist in our eye center. Subject I1
was  diagnosed  to  have  age-related  cataract  with  nuclear
sclerosis on his first visit at 71 years of age. Since the lenses
lost  transparency,  it  was  hard  to  determine  whether  lens
opacification existed before or after nuclear sclerosis and the
type  of  opacities.  His  horizontal  corneal  diameters  were
measured as 10 mm in both eyes at 79 years of age. All five
affected members showed a microcornea phenotype with the
horizontal  corneal  diameter  (ranging  from  9.5  mm  to
10.5 mm) smaller than the defined 11 mm. Subjects II9 and
III5 had microphthalmia. The antero-posterior length of the
globe was less than 20 mm. All cataract subjects were phakic
with mild to mediate vision impairment. Refractive errors
included myopia, hyperopia, and astigmatism. The intraocular
pressure of each subject was within normal range. They did
not have other ocular abnormalities or systemic diseases.
Cataract-causing mutation: Linkage analysis with SNPs and
microsatellite  markers  was  performed.  Twelve  of  fifteen
candidate cataract-causing genes were excluded. Three genes,
namely  CRYAA  (D21S1890;  LOD  score  1.81),  CRYBA1
(D17S1873; LOD score 0), and MAF (D16S3040; LOD score
0), could not be screened because the selected markers were
not sufficiently informative and were not directly sequenced.
One heterozygous C>T transition at the 34th coding position
(c.34C>T) in exon 1 of CRYAA (NM_000394) was identified
(Figure 2). It caused a substitution of arginine with cysteine
at the 12th amino acid position (R12C) and segregated with
cataract in the family. Neither the unaffected members nor the
130 control subjects carried this base change. No sequence
change was identified in CRYBA1 or MAF.
Protein  feature  of  the  R12C  αA-crystallin  mutation:
Recombinant myc/His-tagged wild type or R12C CRYAA
was  transiently  expressed  in  COS-7  cells.  In  cell  lysate
extracted by radioimmunoprecipitation assay buffer, both the
wild  type  and  R12C  CRYAA-myc-His  fusion  proteins
migrated in a single band at approximately 25 kDa when
examined by western blotting with monoclonal anti-CRYAA
antibody or polyclonal anti-myc or anti-His antibody (Figure
3A). When transfected cells were extracted with 0.5% Tx and
subsequently fractionated to obtain Tx-soluble and -insoluble
proteins, the majority of R12C CRYAA was detectable in Tx-
soluble fractions, similar to that of the wild type (Figure 3B).
Only a trace of mutant protein was observable in Tx-insoluble
fractions.  After  being  normalized  with  GAPDH  (for  Tx-
soluble proteins) or β-actin (for Tx-insoluble proteins), band
densitometry revealed that the expression amount in either
Tx-soluble or insoluble fractions had no significant difference
between wild type and R12C CRYAA (p>0.05, Student’s t-
test;  Figure  3B).  The  results  were  consistent  in  triplicate
experiments.
Cytoplasmic  distribution  of  wild  type  and  the  R12C  αA-
crystallin  mutant:  Immunofluorescence  revealed  that  both
wild type (Figure 3C,D) and R12C CRYAA (Figure 3E,F)
were located mainly in the cytoplasm. Some transfected cells
also showed minor nuclear staining of CRYAA, which might
be due to the overexpression of the protein.
Heat-shock responses: COS-7 cells expressing wild type or
R12C CRYAA were incubated at 42 °C for 20 min and then
at  37  °C  for  different  time  intervals.  Steady-state  RNA
expression  of  HSP70  and  HSP90α  was  investigated  by
quantitative  PCR  (qPCR).  Each  reaction  was  done  in
quadruplicate, and the mean signal reading was normalized
with that of GAPDH. Data from different time points were
compared to the non-heat-treated control. We detected a time-
dependent change of the HSP70 expression (Figure 4). For
cells expressing wild type CRYAA, the HSP70 RNA level
began to increase shortly after cells were returned to 37 °C
and reached a peak level after 40 min. The level was about 25
fold higher than the non-heat-treated control and about 12 fold
Molecular Vision 2009; 15:1127-1138 <http://www.molvis.org/molvis/v15/a120> © 2009 Molecular Vision
1132T
A
B
L
E
 
4
.
 
C
L
I
N
I
C
A
L
 
F
E
A
T
U
R
E
S
 
O
F
 
T
H
E
 
A
F
F
E
C
T
E
D
 
F
A
M
I
L
Y
 
M
E
M
B
E
R
S
.
P
a
t
i
e
n
t
s
A
g
e
(
y
e
a
r
s
)
G
e
n
d
e
r
E
y
e
B
e
s
t
c
o
r
r
e
c
t
e
d
v
i
s
u
a
l
 
a
c
u
i
t
y
H
o
r
i
z
o
n
t
a
l
c
o
r
n
e
a
l
d
i
a
m
e
t
e
r
 
(
m
m
)
C
o
r
n
e
a
l
c
u
r
v
a
t
u
r
e
r
a
d
i
u
s
 
(
m
m
)
C
e
n
t
r
a
l
c
o
r
n
e
a
l
t
h
i
c
k
n
e
s
s
(
µ
m
)
A
v
e
r
a
g
e
a
x
i
a
l
 
l
e
n
g
t
h
(
m
m
)
T
y
p
e
 
o
f
c
a
t
a
r
a
c
t
N
y
s
t
a
g
m
u
s
I
1
7
9
M
R
i
g
h
t
2
0
/
5
0
1
0
6
.
7
2
5
5
0
2
0
.
1
1
B
i
l
a
t
e
r
a
l
n
u
c
l
e
u
s
s
c
l
e
r
o
s
i
s
N
o
L
e
f
t
2
0
/
5
0
1
0
6
.
7
5
5
0
2
0
.
0
3
I
I
3
5
3
M
R
i
g
h
t
2
0
/
3
5
9
.
5
6
.
8
6
5
2
0
2
1
.
4
5
L
a
m
e
l
l
a
r
c
a
t
a
r
a
c
t
Y
e
s
L
e
f
t
2
0
/
3
5
9
.
5
6
.
7
5
1
0
2
0
.
5
6
n
u
c
l
e
a
r
d
e
n
s
e
o
p
a
c
i
t
y
I
I
I
5
9
M
R
i
g
h
t
2
0
/
4
0
1
0
6
.
9
1
5
5
0
1
8
.
8
5
B
i
l
a
t
e
r
a
l
l
a
m
e
l
l
a
r
c
a
t
a
r
a
c
t
Y
e
s
L
e
f
t
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
0
/
4
0
9
.
5
6
.
9
8
5
5
0
1
9
.
0
1
I
I
5
5
2
F
R
i
g
h
t
2
0
/
3
5
1
0
.
5
6
.
6
8
5
7
0
2
1
.
8
3
B
i
l
a
t
e
r
a
l
 
d
o
t
c
a
t
a
r
a
c
t
N
o
L
e
f
t
2
0
/
3
0
1
0
.
5
6
.
7
5
7
0
2
1
.
2
6
I
I
9
4
6
F
R
i
g
h
t
2
0
/
3
0
1
0
6
.
8
8
5
3
0
1
9
.
7
3
D
o
t
 
c
a
t
a
r
a
c
t
N
o
L
e
f
t
2
0
/
5
0
1
0
6
.
7
7
5
3
0
1
9
.
6
4
l
a
m
e
l
l
a
r
c
a
t
a
r
a
c
t
T
h
e
 
a
g
e
 
g
i
v
e
n
 
i
s
 
w
h
e
n
 
t
h
e
 
o
p
h
t
h
a
l
m
i
c
 
e
x
a
m
i
n
a
t
i
o
n
 
w
a
s
 
d
o
n
e
.
 
T
h
e
 
a
v
e
r
a
g
e
 
c
o
r
n
e
a
l
 
d
i
a
m
e
t
e
r
 
i
s
 
9
.
9
5
±
0
.
3
7
 
m
m
,
 
t
h
e
 
a
v
e
r
a
g
e
 
c
o
r
n
e
a
l
 
c
u
r
v
a
t
u
r
e
 
r
a
d
i
u
s
 
i
s
 
6
.
7
9
±
0
.
1
1
m
m
,
 
t
h
e
 
a
v
e
r
a
g
e
 
c
e
n
t
r
a
l
 
c
o
r
n
e
a
l
 
t
h
i
c
k
n
e
s
s
 
i
s
 
5
4
3
±
2
0
 
µ
m
,
 
a
n
d
 
t
h
e
 
a
v
e
r
a
g
e
 
a
x
i
a
l
 
l
e
n
g
t
h
 
i
s
 
2
0
.
2
4
7
±
1
.
0
1
 
m
m
.
 
M
:
 
M
a
l
e
;
 
F
:
 
F
e
m
a
l
e
.
Molecular Vision 2009; 15:1127-1138 <http://www.molvis.org/molvis/v15/a120> © 2009 Molecular Vision
1133Figure  3.  R12C  CRYAA  protein
features.  A:  Western  blot  analysis  is
shown of total CRYAA expression in
transfected  COS-7  cells  lysed  with
RIPA. The total amount of mutant R12C
CRYAA expressed in COS-7 cells was
similar to that of wild type (WT). “-”
represents the CRYAA amount in cells
transfected  with  vector  only.  The
expression  of  housekeeping  GAPDH
and β-actin is shown as reference. Band
densitometry verified that there was no
significant difference between WT and
R12C  mutant  amounts  after  being
corrected  by  GAPDH  expression.  In
band densitometry, bars represent SD.
B: Detergent solubility of WT and R12C
mutant  is  analyzed.  The  amount  of
R12C  in  Tx-soluble  fractions  was
similar to that of WT. Only a trace of
R12C  mutant  was  detected  in  Tx-
insoluble fractions. However, there was
no significant difference between WT
and  R12C  mutant  amounts  after
normalization  by  the  housekeeping
protein  expression.  C-F:  The
subcellular  distribution  of  WT  and
R12C  CRYAA  in  COS-7  cells  is
analyzed  as  well.  The  transient
expression  of  recombinant  myc/His-
tagged WT and R12C in COS-7 cells
was detected by anti-CRYAA (C and
E) and anti-myc antibodies (D and F),
respectively. Both the WT (C,D) and
mutant  proteins  (E,F)  were
predominantly  localized  in  the
cytoplasm.  The  red  fluorescence
indicates  the  expression  of  CRYAA,
which was overlaid with DAPI-stained
nucleus in blue color. Scale bar: 50 µm.
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1134higher than samples from cells transfected with the vector
only. It was then reduced and maintained at a low level, close
to that of the 0 min time. This pattern of changing HSP70 RNA
levels  was  shifted  in  cells  expressing  R12C  CRYAA.  A
biphasic  change  was  observed.  The  HSP70  RNA  level
increased shortly after cells were returned to 37 °C incubation.
The level was about 12 fold higher than that of the untreated
control  and  about  6  fold  higher  than  samples  from  cells
transfected  with  vector  only.  The  RNA  level  dropped  to
approximately 60% of the peak level followed by a second
increase to a level about 40 fold more than that of the control
and reached a peak at 120 min. It was then reduced and
remained low for 480 min. Similar results were obtained in
three  independent  experiments  and  when  qPCR  was
performed using another pair of HSP70 specific primers. For
HSP90α, steady-state RNA levels remained constant in cells
expressing either wild type or R12C CRYAA for all time
points after heat stress (Figure 4).
Computational analysis: The theoretical pI of R12C CRYAA
was slightly reduced to 5.6 compared to wild type CRYAA pI
of 5.77. The MW of the mutant was reduced to 19,856 Da
from the MW of wild type CRYAA of 19,909 Da. The R12C
Figure 4. Time-dependent expression of HSP70 and HSP90α. A:
Time-dependent expression of HSP70 is shown of cells expressing
WT or R12C CRYAA and cells transfected with vector only. In WT
CRYAA expressing cells, the HSP70 expression reached to a peak
level 40 min after heat shock while in R12C expressing cells, HSP70
expression showed a biphasic curve and reached the highest level at
120 min. B: The HSP90α expression remained constant among all
time points in cells expressing either WT or R12C CRYAA and in
cells transfected with vector only.
mutation caused no evident structural change to the protein by
PolyPhen  analysis.  However,  the  ProtScale  prediction
illustrated  an  increase  of  local  hydrophobicity  around  the
substitution site (Figure 5).
DISCUSSION
In this study, we first reported a heterozygous mutation c.
34C>T in exon 1 of CRYAA in a Chinese family affected with
non-progressive variable inherited cataract and microcornea.
This led to an amino acid substitution, R12C, close to the
NH2-terminus of CRYAA.
Congenital  cataract-microcornea  (CCMC;  OMIM
116150) syndrome is characterized by lens opacity and a
corneal  diameter  smaller  than  11  mm  [20,21].  It  can  be
associated with other ocular manifestations including myopia,
Figure 5. Altered hydrophobicity of R12C CRYAA protein. A: The
hydrophobicity of WT CRYAA was predicted using the ProtScale
program on the Expasy proteomics server. B: Compared to WT,
R12C  dramatically  enhances  the  local  hydrophobicity,  which  is
indicated by the rectangle.
Molecular Vision 2009; 15:1127-1138 <http://www.molvis.org/molvis/v15/a120> © 2009 Molecular Vision
1135iris coloboma, nystagmus, and microphthalmia [10,25]. One
reported  family  with  an  autosomal  recessive  mode  of
inheritance had a mutation in CRYAA (R54C) [26]. Other
CCMC (OMIM 116150) families inherited the disease in an
autosomal dominant pattern [9-19]. Thirteen mutations in six
genes  have  been  identified  to  cause  autosomal  dominant
CCMC  (OMIM  116150).  They  include  missense  R12C,
R21W, R116H, and R116C mutations of CRYAA [10-13]; a
translational read-through mutation X253R of CRYBB1 [14];
a premature truncation mutation, Y134X, of CRYGD [10];
V44E, P189L, and R198Q in GJA8 [9,10]; R288P, K297R,
and R299 in MAF [15-17]; and Q215X in SCL16A12 [18].
Interfamilial,  intrafamilial,  and  interocular  variations  of
cataract phenotype could be caused by CRYAA mutations. For
example, the R116C mutation in CRYAA led to fan-shaped
cataracts in one family [12] and zonular central nuclear lens
opacities in another family [13]. The affected members from
a family carrying the R116H mutation of CRYAA exhibited
variable lens phenotypes [11].
In this family, all cataract subjects had different severities
of microcornea, some of them with microphthalmia. Although
all  affected  subjects  carried  the  R12C  mutation,  variable
opacities among individuals and between eyes were presented
within the family. The size and location of lens opacities had
no obvious progression during the eight-year follow-up. The
clinical features were compatible with the diagnosis of non-
progressive  cataract-microcornea  with  clinical  variability.
This  phenotype  was  different  from  the  Danish  family
described by Hansen’s [10] group with an affected individual
carrying the R12C mutation showing posterior polar opacity
progressing  to  dense  nuclear  and  laminar  cataract.  The
proband’s corneal diameter was 9.5 mm. Both the cataract
progression and opacity morphology of this individual were
different from our non-progressive cataract.
A total of nine CRYAA mutations have been reported to
cause inherited cataract. Among them, R12C [10], R21W
[10], R54C [26], R116C [12,13], and R116H [10,11] have
been associated with cataract-microcornea syndrome. They
are located in the highly conserved arginine residues in two
major functional domains of the αA-crystallin, the crystallin
domain near the NH2-terminus and the heat-shock domain
near the COOH-terminus. The COOH-terminal domain was
important  for  substrate-binding  ability  and  chaperoning
activity [27]. The NH2-terminus was reported to assist protein
oligomerization, stability, and substrate binding [28]. It is
reasonable to assume that changes in the NH2-terminus that
disturb  subunit  binding  would  greatly  affect  the  general
functioning  of  the  protein  including  reduced  chaperoning
activity. The substitution strongly underscores the importance
of the bulky polar amino acid, arginine, in the conformation
of the CRYAA protein and oligomeric assembly. Loss of
arginine would cause a loss of positive charge and lead to a
change  of  intra-  or  interpeptide  bonding  and  folding.
Functional  studies  have  shown  that  loss  of  arginine
destabilizes CRYAA, reducing its interactions with substrate
proteins  and  chaperoning  activity  [29].  The  phenotype  of
cataract is presumed to be caused by the reduced CRYAA
molecular chaperoning ability on other lens proteins [30]. The
associated microcornea might be due to the inductive effects
from  the  abnormally  formed  lens  on  the  cornea  during
embryogenesis [13]. There are other mutations in CRYAA
reported to cause a cataract phenotype without microcornea.
R21L [31], R49C [32], and G98R [33] were associated with
the autosomal dominant form while W9X [34] was associated
with  the  autosomal  recessive  mode.  This  divergence  of
CRYAA mutations causing cataract-microcornea syndrome or
cataract alone could have different explanations. It is probable
that some lens changes may affect cornea development while
others do not. Moreover, the corneal size changes might not
be obvious in some cases and thus are neglected in routine
examinations.
To  demonstrate  the  effect  of  R12C  substitution  on
CRYAA  chaperoning  activity,  we  used  a  cell  heat  stress
model. Myc-tagged recombinant CRYAA was expressed in
COS-7 cells, which were subjected to heat stress. The heat-
shock response was monitored by the expression of heat-
shock proteins. We demonstrated that HSP70 expression was
different in cells expressing R12C CRYAA whan compared
to  wild  type  CRYAA.  Stress-inducible  HSP70  is  one
chaperone  molecule  that  cooperates  with  multiple  other
chaperones [35] to assist in folding and to reduce aggregation
of client proteins [36,37] and permanently disposes misfolded
proteins  via  the  lysosomal  [38]  or  ubiquitin-proteasome
pathway  [39].  It  was  noted  that  Hsp70  was  strongly  and
specifically expressed in the embryonic lens of zebrafish for
a short period of time and that it was required for normal lens
formation [40,41]. Similar expression was also detected in
embryonic chicken and human lens [42-44]. In zebrafish, the
inhibition  of  Hsp70  expression  may  lead  to  small  eye
phenotype, characterized by underdeveloped lens [45]. In our
study, R12C CRYAA expressing cells exhibited an altered
HSP70 expression when compared with cells expressing wild
type CRYAA. The result suggested that the R12C mutation
causes  CCMC  in  our  Chinese  family  possibly  through
delaying  or  decreasing  HSP70  expression  during  lens
development.
Protein analysis by ProtScale clearly showed an increase
of local hydrophobicity around the Arg-Cys substitution site
in CRYAA (Figure 5). As exhibited in other lens proteins,
hydrophobicity  is  associated  with  crystallin  activities.
Increased hydrophobic interaction could reduce solubility of
CRYBB2 [46]. Normal folding of CRYGD was maintained
by  the  hydrophobic  interface  [47,48].  For  CRYAA,
hydrophobicity was involved in protein oligomerization and
chaperoning activity [49,50]. Hence, the predicted shift of
hydrophobicity due to the R12C change might alter the local
protein structure and contact interfaces, which subsequently
results  in  changes  of  protein  function.  Using  PolyPhen
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1136analysis to predict the effect of amino acid change on protein
structure and function, R12C CRYAA did not cause major
structural  changes  when  compared  to  the  wild  type.
Additionally, a slight reduction of theoretical isoelectric point
from 5.77 to 5.60 and of molecular weight from 19,909 to
19,856 Da was noted. Their effect on the CRYAA structure
has to be further investigated.
In conclusion, the c.34C>T mutation in CRYAA that leads
to  the  R12C  substitution  segregated  with  stable  inherited
cataract  in  a  Chinese  family.  It  was  associated  with
microcornea  and  microphthalmia.  Expression  of  R12C
CRYAA with altered chaperoning capability modified the
heat-shock  response  of  affected  cells.  Such  an  altered
CRYAA  property  may  be  related  to  the  development  of
CCMC (OMIM 116150).
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